BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9569946)

  • 1. Review of the estrogenic and antiestrogenic activity of polycyclic aromatic hydrocarbons: relationship to carcinogenicity.
    Santodonato J
    Chemosphere; 1997 Feb; 34(4):835-48. PubMed ID: 9569946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiestrogenicity of environmental polycyclic aromatic hydrocarbons in human breast cancer cells.
    Arcaro KF; O'Keefe PW; Yang Y; Clayton W; Gierthy JF
    Toxicology; 1999 Apr; 133(2-3):115-27. PubMed ID: 10378478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogenic activity of environmental polycyclic aromatic hydrocarbons in uterus of immature Wistar rats.
    Kummer V; Masková J; Zralý Z; Neca J; Simecková P; Vondrácek J; Machala M
    Toxicol Lett; 2008 Aug; 180(3):212-21. PubMed ID: 18634860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycyclic aromatic hydrocarbons: physicochemical properties, environmental appearance and impact on living organisms.
    Skupińska K; Misiewicz I; Kasprzycka-Guttman T
    Acta Pol Pharm; 2004; 61(3):233-40. PubMed ID: 15481250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-estrogenic activity of selected polynuclear aromatic hydrocarbons in yeast expressing human estrogen receptor.
    Tran DQ; Ide CF; McLachlan JA; Arnold SF
    Biochem Biophys Res Commun; 1996 Dec; 229(1):101-8. PubMed ID: 8954090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation of cell proliferation by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells reflects both genotoxic and nongenotoxic events.
    Plísková M; Vondrácek J; Vojtesek B; Kozubík A; Machala M
    Toxicol Sci; 2005 Feb; 83(2):246-56. PubMed ID: 15548639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, function and carcinogenicity of metabolites of methylated and non-methylated polycyclic aromatic hydrocarbons: a comprehensive review.
    Flesher JW; Lehner AF
    Toxicol Mech Methods; 2016; 26(3):151-79. PubMed ID: 26894797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the obvious: Environmental health implications of polar polycyclic aromatic hydrocarbons.
    Idowu O; Semple KT; Ramadass K; O'Connor W; Hansbro P; Thavamani P
    Environ Int; 2019 Feb; 123():543-557. PubMed ID: 30622079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential action of polycyclic aromatic hydrocarbons on endogenous estrogen-responsive genes and on a transfected estrogen-responsive reporter in MCF-7 cells.
    Gozgit JM; Nestor KM; Fasco MJ; Pentecost BT; Arcaro KF
    Toxicol Appl Pharmacol; 2004 Apr; 196(1):58-67. PubMed ID: 15050408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of airborne polycyclic aromatic hydrocarbons (PAHs) and their human health effects.
    Kim KH; Jahan SA; Kabir E; Brown RJ
    Environ Int; 2013 Oct; 60():71-80. PubMed ID: 24013021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycyclic Aromatic Hydrocarbons (PAHs) and their Bioaccessibility in Meat: a Tool for Assessing Human Cancer Risk.
    Hamidi EN; Hajeb P; Selamat J; Abdull Razis AF
    Asian Pac J Cancer Prev; 2016; 17(1):15-23. PubMed ID: 26838201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycyclic aromatic hydrocarbons in carcinogenesis.
    Warshawsky D
    Environ Health Perspect; 1999 Apr; 107(4):317-9. PubMed ID: 10090712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl hydrocarbon receptor-mediated and estrogenic activities of oxygenated polycyclic aromatic hydrocarbons and azaarenes originally identified in extracts of river sediments.
    Machala M; Ciganek M; Bláha L; Minksová K; Vondráck J
    Environ Toxicol Chem; 2001 Dec; 20(12):2736-43. PubMed ID: 11764156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potency equivalency factors for some polycyclic aromatic hydrocarbons and polycyclic aromatic hydrocarbon derivatives.
    Collins JF; Brown JP; Alexeeff GV; Salmon AG
    Regul Toxicol Pharmacol; 1998 Aug; 28(1):45-54. PubMed ID: 9784432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological effects of polycyclic aromatic hydrocarbon derivatives.
    Bekki K; Toriba A; Tang N; Kameda T; Hayakawa K
    J UOEH; 2013 Mar; 35(1):17-24. PubMed ID: 23475020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological impact of environmental polycyclic aromatic hydrocarbons (ePAHs) as endocrine disruptors.
    Zhang Y; Dong S; Wang H; Tao S; Kiyama R
    Environ Pollut; 2016 Jun; 213():809-824. PubMed ID: 27038213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytotherapeutic approach: a new hope for polycyclic aromatic hydrocarbons induced cellular disorders, autophagic and apoptotic cell death.
    Das DN; Panda PK; Naik PP; Mukhopadhyay S; Sinha N; Bhutia SK
    Toxicol Mech Methods; 2017 Jan; 27(1):1-17. PubMed ID: 27919191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genotoxicity of priority polycyclic aromatic hydrocarbons in complex mixtures.
    White PA
    Mutat Res; 2002 Mar; 515(1-2):85-98. PubMed ID: 11909757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a 2-D geometric descriptor associated with non-genotoxic carcinogens and some estrogens and antiestrogens.
    Rosenkranz HS; Cunningham A; Klopman G
    Mutagenesis; 1996 Jan; 11(1):95-100. PubMed ID: 8671723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycyclic Aromatic Hydrocarbons: Part I. Exposure.
    Ifegwu OC; Anyakora C
    Adv Clin Chem; 2015; 72():277-304. PubMed ID: 26471085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.